Product image of Isoket (Isosorbide Dinitrate) supplied by GNH India

Isoket

Active Ingredient:
Isosorbide Dinitrate
Origin:
EU

Isoket (Isosorbide Dinitrate)

Isosorbide dinitrate, the active ingredient in Isoket, is a nitrate vasodilator presented as an intravenous solution for intravenous use. It is indicated for the management of angina pectoris and heart failure in adult patients, providing rapid relief of myocardial ischemia.

GNH India supplies Isoket as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, clinics and procurement teams worldwide, ensuring quality‑controlled distribution in accordance with EU regulatory standards. The company’s network enables reliable supply chains to meet global urgent clinical needs.

Manufacturer / TM Owner

Merus Labs Luxco Ii S.À R.L.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Isoket (isosorbide dinitrate) belongs to the nitrate vasodilator class and is employed to manage cardiovascular conditions that involve myocardial oxygen demand.

  • Angina pectoris: reduces frequency and severity of chest pain by dilating coronary arteries.
  • Heart failure: improves cardiac output by decreasing preload and afterload.
  • Prophylaxis of angina attacks during exertion: provides preventive relief for patients with known coronary artery disease.

How It Works

  • Isosorbide dinitrate releases nitric oxide in vascular smooth muscle, activating soluble guanylate cyclase and increasing cyclic GMP levels. Elevated cGMP leads to relaxation of smooth muscle cells, causing vasodilation of veins and arteries, which lowers cardiac preload and afterload and reduces myocardial oxygen consumption.

Side Effects

Isoket may cause a range of adverse reactions, which are categorized by frequency.

Common Side Effects

  • Headache: throbbing pain often occurring shortly after administration.
  • Hypotension: noticeable drop in blood pressure, sometimes accompanied by dizziness.
  • Flushing: warm sensation and reddening of the skin.
  • Dizziness or light‑headedness: especially when standing quickly.
  • Nausea: mild gastrointestinal upset.
  • Tachycardia: compensatory increase in heart rate.

Serious or Rare Side Effects

  • Severe hypotension: can lead to syncope or shock.
  • Myocardial infarction: rare but possible in susceptible patients.
  • Life‑threatening arrhythmias: irregular heart rhythms requiring immediate care.
  • Syncope: sudden loss of consciousness.
  • Allergic reaction: rash, itching, or anaphylaxis.
  • Methemoglobinemia: abnormal hemoglobin causing reduced oxygen delivery.

Precautions & Warnings

Before using Isoket, clinicians should consider several safety measures.

  • Monitor blood pressure: avoid excessive hypotension, especially in volume‑depleted patients.
  • Avoid concurrent use with phosphodiesterase‑5 inhibitors: risk of profound hypotension.
  • Use with caution in patients with severe anemia: nitrates may exacerbate tissue hypoxia.
  • Assess for nitrate tolerance: consider nitrate‑free intervals to maintain efficacy.
  • Store at below 25°C: keep in the original container, protect from light and moisture.

Avoid Interactions

Isoket can interact with several drug classes; awareness of these interactions helps prevent adverse events.

Major Interactions (Avoid)

  • Sildenafil, tadalafil, and other PDE5 inhibitors: may cause severe hypotension.
  • Other nitrates (e.g., nitroglycerin): additive vasodilatory effect leading to dangerous blood pressure drops.
  • Sodium nitrite: increased nitrite levels can precipitate methemoglobinemia.

Moderate Interactions (Monitor Closely)

  • Antihypertensives such as ACE inhibitors or beta‑blockers: additive blood pressure lowering.
  • Diuretics: may enhance hypotensive response.
  • Alcohol: can increase vasodilatory effects and dizziness.

Frequently Asked Questions

Isoket contains isosorbide dinitrate and is indicated for the management of angina pectoris and heart failure in adult patients. It provides rapid vasodilation to relieve myocardial ischemia and improve cardiac output in acute care settings.

Isosorbide dinitrate donates nitric oxide, which activates soluble guanylate cyclase in vascular smooth muscle. This raises cyclic GMP levels, leading to smooth‑muscle relaxation, venous and arterial dilation, reduced preload and afterload, and consequently lower myocardial oxygen demand.

The dosing regimen for Isoket is individualized. The prescribing clinician determines the appropriate infusion rate, concentration, and duration based on the patient’s clinical condition, response, and tolerance, following local guidelines and product labeling.

Safety of isosorbide dinitrate in pregnancy and lactation has not been established. It should be used only if the potential benefit justifies any potential risk to the fetus or infant, and under close medical supervision.

Submit an enquiry on the Isoket product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Isoket delivers rapid onset via intravenous infusion, making it suitable for acute angina or heart‑failure episodes, whereas oral nitrates have slower absorption. Unlike beta‑blockers or calcium‑channel blockers, it works by nitric‑oxide mediated vasodilation and has a distinct side‑effect profile.

Store Isoket at below 25 °C in its original container, protecting it from light and moisture. Do not freeze the solution, and keep it away from sources of heat. Follow standard aseptic techniques when preparing the IV infusion.

Isoket is administered by a qualified healthcare professional as an intravenous infusion. The solution is diluted according to the prescribing information and delivered through a controlled IV line, with continuous monitoring of blood pressure and heart rate during administration.

Serious risks include severe hypotension, myocardial infarction, life‑threatening arrhythmias, syncope, and allergic reactions such as anaphylaxis. Immediate medical attention is required if any of these events occur during or after infusion.

Patients with known hypersensitivity to isosorbide dinitrate or other nitrates, severe anemia, recent use of phosphodiesterase‑5 inhibitors, or uncontrolled hypotension should avoid Isoket. Its use must be evaluated by a physician for each individual case.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.